Pristiq: An Update
The Carlat Psychiatry Report, Volume 7, Number 10, October 2009
https://www.thecarlatreport.com/newsletter-issue/tcprv7n10/
Issue Links: Learning Objectives | Editorial Information
Topics: Antidepressants
Daniel Carlat, MD
Pristiq (desvenlafaxine extendedrelease tablet) was approved by the FDA in February of 2008 for the treatment of major depression.
You can't view details of this content, please login or buy subscription here
Daniel Carlat, MD
Editor-in-Chief, Publisher, The Carlat Report.
Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.